Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Publications

Recent publications published by researchers at the MRC WIMM.

The road to refractory graft-versus-host disease is paved with good intentions

Journal article

North D. and Chakraverty R., (2024), Journal of Clinical Investigation, 134

ALL-RIC trial protocol: a comparison of reduced dose total body irradiation (TBI) and cyclophosphamide with fludarabine and melphalan reduced intensity conditioning in adults with acute lymphoblastic leukaemia (ALL) in complete remission.

Journal article

Marks DI. et al, (2023), BMJ Open, 13

Allogeneic stem cell transplantation compared to conservative management in adults with inborn errors of immunity.

Journal article

Cheminant M. et al, (2022), Blood

CAR-T Cells and Recent Advances in Clinical Cellular Immunotherapy

Chapter

Gu Y. et al, (2022), Practical Transfusion Medicine: Sixth Edition, 543 - 553

Graft Versus Leukaemia (GvL): Identification & Characterisation of Alloreactive Antigens and Cognate T Cell Responses in Acute Myeloid Leukemia

Conference paper

Sweeney C. et al, (2022), BLOOD, 140, 1576 - 1578

Allogeneic HSCT For Adolescents and Adults With Inborn Errors of Immunity: A Retrospective Study of The Inborn Errors Working Party (IEWP)

Conference paper

Albert M. et al, (2021), BONE MARROW TRANSPLANTATION, 56, 101 - 102

Correction to: Idelalisib treatment prior to allogeneic stem cell transplantation for patients with chronic lymphocytic leukemia: a report from the EBMT chronic malignancies working party (Bone Marrow Transplantation, (2021), 56, 3, (605-613), 10.1038/s41409-020-01069-w)

Journal article

Schetelig J. et al, (2021), Bone Marrow Transplantation

Phenotype Reversal, Excellent Overall, GVHD-free And Graft Failure-Free Survival In 55 Adolescents And Adults With Inborn Errors of Immunity Following Reduced Intensity Allogeneic HSCT

Conference paper

Fox TA. et al, (2021), BONE MARROW TRANSPLANTATION, 56, 103 - 105

Predictors of recovery following allogeneic CD34+-selected cell infusion without conditioning to correct poor graft function.

Journal article

Cuadrado MM. et al, (2020), Haematologica, 105, 2639 - 2646

Very Long-Term Follow Up of 83 Adults WHO Underwent Allogeneic HSCT in Childhood for Primary Immunodeficiency (PID): A Single Centre Experience

Conference paper

Day J. et al, (2020), BONE MARROW TRANSPLANTATION, 55, 106 - 106

CMV-Specific T-Cell Therapy Improves Immune Reconstitution Following Unrelated Donor HSCT: Results of a Randomized Controlled Trial

Conference paper

Chen F. et al, (2014), BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 20, S49 - S49